Go to JCI Insight
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
  • Clinical Research and Public Health
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Gastroenterology
    • Immunology
    • Metabolism
    • Nephrology
    • Neuroscience
    • Oncology
    • Pulmonology
    • Vascular biology
    • All ...
  • Videos
    • ASCI Milestone Awards
    • Video Abstracts
    • Conversations with Giants in Medicine
  • Reviews
    • View all reviews ...
    • The cGAS-STING pathway: DNA sensing in health and disease (Jun 2026)
    • Neurodegeneration (Mar 2026)
    • Clinical innovation and scientific progress in GLP-1 medicine (Nov 2025)
    • Pancreatic Cancer (Jul 2025)
    • Complement Biology and Therapeutics (May 2025)
    • Evolving insights into MASLD and MASH pathogenesis and treatment (Apr 2025)
    • Microbiome in Health and Disease (Feb 2025)
    • View all review series ...
  • Viewpoint
  • Collections
    • In-Press Preview
    • Clinical Research and Public Health
    • Research Letters
    • Letters to the Editor
    • Editorials
    • Commentaries
    • Editor's notes
    • Reviews
    • Viewpoints
    • 100th anniversary
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • Reviews
  • Review series
  • ASCI Milestone Awards
  • Video Abstracts
  • Conversations with Giants in Medicine
  • In-Press Preview
  • Clinical Research and Public Health
  • Research Letters
  • Letters to the Editor
  • Editorials
  • Commentaries
  • Editor's notes
  • Reviews
  • Viewpoints
  • 100th anniversary
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
A de novo TLR7 gain-of-function mutation causing severe monogenic lupus in an infant
Jarmila Stremenova Spegarova, Praisoody Sinnappurajar, Dalila Al Julandani, Rokas Navickas, Helen Griffin, Manisha Ahuja, Angela Grainger, Katie Livingstone, Gillian I. Rice, Fraser Sutherland, Corinne Hayes, Simon Parke, Lewis Pang, Marion R. Roderick, Mary Slatter, Yanick Crow, Athimalaipet V. Ramanan, Sophie Hambleton
Jarmila Stremenova Spegarova, Praisoody Sinnappurajar, Dalila Al Julandani, Rokas Navickas, Helen Griffin, Manisha Ahuja, Angela Grainger, Katie Livingstone, Gillian I. Rice, Fraser Sutherland, Corinne Hayes, Simon Parke, Lewis Pang, Marion R. Roderick, Mary Slatter, Yanick Crow, Athimalaipet V. Ramanan, Sophie Hambleton
View: Text | PDF
Research Letter Autoimmunity Immunology

A de novo TLR7 gain-of-function mutation causing severe monogenic lupus in an infant

  • Text
  • PDF
Abstract

Authors

Jarmila Stremenova Spegarova, Praisoody Sinnappurajar, Dalila Al Julandani, Rokas Navickas, Helen Griffin, Manisha Ahuja, Angela Grainger, Katie Livingstone, Gillian I. Rice, Fraser Sutherland, Corinne Hayes, Simon Parke, Lewis Pang, Marion R. Roderick, Mary Slatter, Yanick Crow, Athimalaipet V. Ramanan, Sophie Hambleton

×

Figure 1

TLR7 gain-of-function mutation in a young child with severe SLE.

Options: View larger image (or click on image) Download as PowerPoint
TLR7 gain-of-function mutation in a young child with severe SLE.
(A) Per...
(A) Persistently pathologically elevated interferon-stimulated gene and (B) neutrophil signature gene transcripts in patient at indicated time points. The y axis shows transcript abundance in arbitrary units (relative quantification [RQ] values) for indicated genes. (C) Pedigree. (D) Capillary sequencing of PCR amplicons. P, proline substituted by L, leucine. (E) Increased transcription of proinflammatory cytokines TNF-α, IL-1b, and IL-6 in patient PBMCs stimulated with TLR7/8 ligand CL097 or polyI:C. US, unstimulated. (F) Increased TLR7 protein expression in patient PBMC subsets quantitated by (G) flow cytometry. Representative of 2 independent experiments. (H) TLR7 protein expression detected by immunoblotting of transfected HEK293T cells 48 hours after transfection. (I) NF-κB activity by dual luciferase assay after TLR7 plasmid transfection into HEK293T cells and treatment with indicated TLR7 ligands. Luminescence signal normalized to unstimulated cells from 4 independent experiments. Two-way ANOVA, **P < 0.01, ****P < 0.0001. Data represent mean ± SD.

Copyright © 2026 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)

Sign up for email alerts